Christopher L. Pin

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Fatemeh Mousavi · 3 shared papers, 2021–2025 · strength 0.53
   • Paper Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS G12D Activation. DOI 10.1016/j.jcmgh.2024.101428↗
   • Paper EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in mice. DOI 10.1172/jci.insight.173746↗
   • Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z↗
2. María Teresa Borrello · 2 shared papers, 2021–2022 · strength 0.38
   • Paper The unfolded protein response: An emerging therapeutic target for pancreatitis and pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2021.10.007↗
   • Paper Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. DOI 10.1038/s41388-021-01771-z↗
3. Joana Ribeiro Pinto · 1 shared paper, 2026 · strength 0.27
   • Paper Examination of DNA methylation patterns in pancreatic ductal adenocarcinoma DOI 10.21203/rs.3.rs-10421877/v1↗
4. Eugenia Flores Figueroa · 1 shared paper, 2026 · strength 0.27
   • Paper Examination of DNA methylation patterns in pancreatic ductal adenocarcinoma DOI 10.21203/rs.3.rs-10421877/v1↗
5. Robert C. Grant · 1 shared paper, 2026 · strength 0.27
   • Paper Examination of DNA methylation patterns in pancreatic ductal adenocarcinoma DOI 10.21203/rs.3.rs-10421877/v1↗
6. Grainne Mary O'Kane · 1 shared paper, 2026 · strength 0.27
   • Paper Examination of DNA methylation patterns in pancreatic ductal adenocarcinoma DOI 10.21203/rs.3.rs-10421877/v1↗
7. Erica S. Tsang · 1 shared paper, 2026 · strength 0.27
   • Paper Examination of DNA methylation patterns in pancreatic ductal adenocarcinoma DOI 10.21203/rs.3.rs-10421877/v1↗
8. Faiyaz Notta · 1 shared paper, 2026 · strength 0.27
   • Paper Examination of DNA methylation patterns in pancreatic ductal adenocarcinoma DOI 10.21203/rs.3.rs-10421877/v1↗
9. Joyce K. Thompson · 1 shared paper, 2025 · strength 0.24
   • Paper Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS G12D Activation. DOI 10.1016/j.jcmgh.2024.101428↗
10. Timothy L. Frankel · 1 shared paper, 2025 · strength 0.24
    • Paper Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS G12D Activation. DOI 10.1016/j.jcmgh.2024.101428↗
11. Filip Bednar · 1 shared paper, 2025 · strength 0.24
    • Paper Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS G12D Activation. DOI 10.1016/j.jcmgh.2024.101428↗
12. Renzo Emanuel Vera · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
13. Ezequiel J. Tolosa · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
14. Brooke R Tader · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
15. Aleksey V. Matveyenko · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
16. Luis F. Flores · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
17. Catherine E. Hagen · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
18. Kayla C. LaRue-Nolan · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
19. Rondell Patrell Graham · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
20. David R Pease · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
21. Ryan Michael Carr · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
22. David W. Dawson · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
23. Martín E. Fernández-Zapico · 1 shared paper, 2025 · strength 0.19
    • Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
24. Emilie Jaune · 1 shared paper, 2024 · strength 0.17
    • Paper EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in mice. DOI 10.1172/jci.insight.173746↗
25. Abdessamad El Kaoutari · 1 shared paper, 2024 · strength 0.17
    • Paper EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in mice. DOI 10.1172/jci.insight.173746↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.